Sebia
Shigehide Onoda has a diverse work experience spanning several industries. Shigehide is currently the Representative Director and President at Sebia since June 2021. Prior to this role, they served as the Executive Director at Fourth Valley Concierge Corporation from April 2017 to May 2021, and as the General Manager from June 2016 to March 2017. Before that, Shigehide worked at Johnson & Johnson. Shigehide held the positions of Senior Marketing Manager from an unknown start date to May 2016, Marketing Manager from July 2011 to December 2013, and was also part of the Commercial Leadership Development Program from September 2009 to June 2011. Shigehide began their career at Dell as an Account Manager from May 2005 to June 2007. Shigehide'searliest work experience was as a Sales Representative at Hitachi from April 1999 to March 2004.
Shigehide Onoda holds a Bachelor of Arts degree in Business Administration and Management, General from Aoyama Gakuin University. Shigehide also obtained an MBA with a focus on Marketing/Marketing Management, General from Vanderbilt University's Owen Graduate School of Management.
This person is not in any offices
Sebia
2 followers
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.